Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
1986-10-22
pubmed:abstractText
Because brief exposure to phorbol esters renders normal cells vulnerable to deformation and cytolysis by lymphocytes, it was postulated that these tumor promoters might cause a hitherto unrecognized physical alteration in membrane architecture. To investigate this possibility, four tissue culture cell lines (K-562 erythroleukemia cells, melanoma cells, N1121 adult fibroblasts, and normal fetal fibroblasts) and three blood cell types (lymphocytes, monocytes, and platelets) were subjected to freeze-fracture analysis before and after brief treatment with phorbol myristate acetate. Phorbol myristate acetate caused a 50% reduction of intramembranous particles associated with the external leaflet (E face) of the plasma membrane of every cell except platelets. In contrast, no change in size or number of intramembranous particles associated with the protoplasmic membrane leaflet (P face) was evident. Since the platelet membrane is known to be turned "inside out," as regards the partition coefficient of the intramembranous particles, the disparity between the results obtained with platelets and other cells may serve to determine the nature of intramembranous particles affected by phorbols. Also, since phorbols affect primarily glycolipids and/or glycoproteins anchored in the external membrane leaflet, these findings may provide a useful tool for future exploration of membrane structure.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-1033935, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-1262468, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-3093088, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-4203359, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-4554989, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-4600883, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-4648341, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-4814896, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-5011015, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-5334198, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-572392, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-6215064, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-6232463, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-6296873, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-6470039, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-6733848, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-6962179, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-7019380, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-7085651, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-7200397, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-7253562, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-7309293, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-7328117, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-762427, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-838771, http://linkedlifedata.com/resource/pubmed/commentcorrection/3462729-954857
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
83
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6829-33
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
Loss of intercalated membrane particles by treatment with phorbols.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.